FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1955983417> ?p ?o ?g. }

• W1955983417 endingPage "886" @default.
• W1955983417 startingPage "879" @default.
• W1955983417 abstract "The 'Migraine Intervention Score' (MIS) is a new self-administered scale that can be used to quantify the severity of specific migraine symptoms. The objective of this study was to determine if MIS could be used to improve the efficacy of frovatriptan 2.5 mg in the early treatment of migraine attacks for clinical practice.In this prospective observational study, patients suffering from migraines with or without aura were enrolled and permitted to choose the time of self-medication with frovatriptan 2.5 mg. At the time of intake of medication, patients evaluated the severity of individual migraine symptoms using MIS. The scores for each symptom were then totalled to provide an overall level of symptom severity. A total of 1620 patients completed the treatment of three migraine attacks with frovatriptan. A total of 1518 patients could be analysed with respect to the documented efficacy parameters of the third attack. Patients initiating treatment at low symptom severity levels were compared with those initiating treatment at high symptom severity levels.Time to the achievement of the primary endpoint (headache response) was significantly lower in patients who initiated treatment at low vs. high symptom severity levels (42.06 ± 32.33 vs. 49.25 ± 34.92 min; p = 0.0023). Likewise, patients who initiated treatment at low symptom severity levels achieved complete headache relief more rapidly (79.37 ± 65.33 vs. 96.05 ± 100.85 min; p = 0.0109) and required escape medication less frequently (3.88% vs. 13.73%; p < 0.0001).The initiation of attack treatment with frovatriptan at low severity of migraine symptoms is more effective than starting therapy at higher symptom levels. Together with the low recurrence headache rate, the decreased necessity for escape medication and the low number of tablets needed, these data demonstrate that operationalised intervention with frovatriptan 2.5 mg is a valuable method for improving the treatment of migraine attacks." @default.
• W1955983417 created "2016-06-24" @default.
• W1955983417 creator A5023113717 @default.
• W1955983417 creator A5028652475 @default.
• W1955983417 date "2011-07-15" @default.
• W1955983417 modified "2023-10-16" @default.
• W1955983417 title "The Migraine Intervention Score - a tool to improve efficacy of triptans in acute migraine therapy: the ALADIN study" @default.
• W1955983417 cites W1639290048 @default.
• W1955983417 cites W1933217530 @default.
• W1955983417 cites W1975132866 @default.
• W1955983417 cites W1978823620 @default.
• W1955983417 cites W1982394358 @default.
• W1955983417 cites W1990698167 @default.
• W1955983417 cites W1995134874 @default.
• W1955983417 cites W2003163400 @default.
• W1955983417 cites W2004518311 @default.
• W1955983417 cites W2005128914 @default.
• W1955983417 cites W2013563301 @default.
• W1955983417 cites W2020016038 @default.
• W1955983417 cites W2021161101 @default.
• W1955983417 cites W2039351165 @default.
• W1955983417 cites W2039942911 @default.
• W1955983417 cites W2043377214 @default.
• W1955983417 cites W2045777987 @default.
• W1955983417 cites W2049192995 @default.
• W1955983417 cites W2054670486 @default.
• W1955983417 cites W2056317944 @default.
• W1955983417 cites W2058027543 @default.
• W1955983417 cites W2063140978 @default.
• W1955983417 cites W2067619280 @default.
• W1955983417 cites W2070619996 @default.
• W1955983417 cites W2072344406 @default.
• W1955983417 cites W2073074795 @default.
• W1955983417 cites W2074627216 @default.
• W1955983417 cites W2075675719 @default.
• W1955983417 cites W2075727278 @default.
• W1955983417 cites W2076572444 @default.
• W1955983417 cites W2078055775 @default.
• W1955983417 cites W2079490818 @default.
• W1955983417 cites W2096198144 @default.
• W1955983417 cites W2104400722 @default.
• W1955983417 cites W2105449779 @default.
• W1955983417 cites W2117047050 @default.
• W1955983417 cites W2126194551 @default.
• W1955983417 cites W2127186410 @default.
• W1955983417 cites W2132975243 @default.
• W1955983417 cites W2138515960 @default.
• W1955983417 cites W2157706533 @default.
• W1955983417 cites W2160202859 @default.
• W1955983417 cites W2166530830 @default.
• W1955983417 cites W2170096433 @default.
• W1955983417 cites W4244642833 @default.
• W1955983417 doi "https://doi.org/10.1111/j.1742-1241.2011.02720.x" @default.
• W1955983417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21762313" @default.
• W1955983417 hasPublicationYear "2011" @default.
• W1955983417 type Work @default.
• W1955983417 sameAs 1955983417 @default.
• W1955983417 citedByCount "3" @default.
• W1955983417 countsByYear W19559834172012 @default.
• W1955983417 countsByYear W19559834172015 @default.
• W1955983417 crossrefType "journal-article" @default.
• W1955983417 hasAuthorship W1955983417A5023113717 @default.
• W1955983417 hasAuthorship W1955983417A5028652475 @default.
• W1955983417 hasBestOaLocation W19559834171 @default.
• W1955983417 hasConcept C126322002 @default.
• W1955983417 hasConcept C1862650 @default.
• W1955983417 hasConcept C188816634 @default.
• W1955983417 hasConcept C23131810 @default.
• W1955983417 hasConcept C2777119127 @default.
• W1955983417 hasConcept C2777350023 @default.
• W1955983417 hasConcept C2778541695 @default.
• W1955983417 hasConcept C2780564907 @default.
• W1955983417 hasConcept C30036603 @default.
• W1955983417 hasConcept C42219234 @default.
• W1955983417 hasConcept C71924100 @default.
• W1955983417 hasConceptScore W1955983417C126322002 @default.
• W1955983417 hasConceptScore W1955983417C1862650 @default.
• W1955983417 hasConceptScore W1955983417C188816634 @default.
• W1955983417 hasConceptScore W1955983417C23131810 @default.
• W1955983417 hasConceptScore W1955983417C2777119127 @default.
• W1955983417 hasConceptScore W1955983417C2777350023 @default.
• W1955983417 hasConceptScore W1955983417C2778541695 @default.
• W1955983417 hasConceptScore W1955983417C2780564907 @default.
• W1955983417 hasConceptScore W1955983417C30036603 @default.
• W1955983417 hasConceptScore W1955983417C42219234 @default.
• W1955983417 hasConceptScore W1955983417C71924100 @default.
• W1955983417 hasIssue "8" @default.
• W1955983417 hasLocation W19559834171 @default.
• W1955983417 hasLocation W19559834172 @default.
• W1955983417 hasOpenAccess W1955983417 @default.
• W1955983417 hasPrimaryLocation W19559834171 @default.
• W1955983417 hasRelatedWork W1633183094 @default.
• W1955983417 hasRelatedWork W1955983417 @default.
• W1955983417 hasRelatedWork W2007421108 @default.
• W1955983417 hasRelatedWork W2398537668 @default.
• W1955983417 hasRelatedWork W2405229463 @default.
• W1955983417 hasRelatedWork W2593513910 @default.
• W1955983417 hasRelatedWork W2904618082 @default.

• next